Ensemble Capital acquired 228 Thousand Illumina shares worth $17.3 Million. That's 1.43% of their equity portfolio (19th largest holding). The first Illumina trade was made in Q4 2020. Since then Ensemble Capital bought shares eleven more times and sold shares on four occasions. The investor's estimated purchase price is $78.4 Million, resulting in a loss of 78%.
On June 25, 2024, Illumina, Inc. (NASDAQ: ILMN, $208.92, Market Capitalization: $18.51 billion) announced the completion of the tax free spin-off of GRAIL, I...
On June 3, 2024, Illumina's (NASDAQ: ILMN, $109.82, Market Capitalization: $17.5 billion) board of directors approved the spin-off of its wholly owned subsid...
Illumina, Inc. (NASDAQ:NASDAQ:ILMN) RBC Capital Markets Global Healthcare Call May 14, 2024 8:30 AM ETCompany ParticipantsAnkur Dhingra - Chief Financial…
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of...